|
業務類別
|
-- |
|
業務概覽
|
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs). |
| 公司地址
| Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052 |
| 電話號碼
| +81 352103290 |
| 傳真號碼
| +81 352103291 |
| 公司網頁
| https://www.nxera.life |
| 員工數量
| 181 |
| Mr. Christopher Cargill |
Chairman of the Board, President, Executive Officer and Chief Executive Officer |
-- |
25/03/2026 |
|
|
| Mr. Christopher Cargill |
Chairman of the Board, President, Executive Officer and Chief Executive Officer |
25/03/2026 |
| Ms. Naoko Shimura |
Independent Director |
25/03/2026 |
| Mr. Rolf Soderstrom |
Independent Director |
25/03/2026 |
| Ms. Nicola Rabson |
Independent Director |
25/03/2026 |
| Ms. Eiko Tomita |
Independent Director |
25/03/2026 |
| Mr. David Roblin |
Independent Director |
25/03/2026 |
| Dr. Takeo Morooka |
Independent Director |
25/03/2026 |
|
|
|
|
